Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis

Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosisBusulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis, Published online: 03 May 2018; doi:10.1038/s41409-018-0175-8Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis

Source: Bone Marrow Transplantation - May 3, 2018 Category: Hematology Authors: Yao Chen Lan-Ping Xu Xiao-Hui Zhang Huan Chen Feng-Rong Wang Kai-Yan Liu Jiong Qin Yan-Ling Yang Xiao-Jun Huang Source Type: research